介入放射学肥胖治疗:SIR基金会研究共识专家组会议纪要
SIR基金会召集多学科专家组,回顾肥胖介入治疗证据并识别研究不足。专家组认为6-12个月体重较基线下降>8%-10%是理想治疗终点,最高优先研究为 blinded 随机对照试验比较介入减重与假手术对照,患者均接受行为治疗。
要点
- 介入减重治疗理想终点为6-12个月体重下降>8%-10%。
- 最高优先研究为盲法随机对照试验对比假手术。
- 试验中患者应同时接受行为治疗。
核心结论
- 专家组共识认为介入减重治疗理想终点为6-12个月体重较基线下降>8%-10%。
- 最高优先研究为设计盲法随机对照试验比较介入减重与假手术对照,患者均接受行为治疗。
研究设计与样本
- SIR基金会委托成立研究共识专家组,召开多学科医生和科学家会议。
- 会议目的是回顾肥胖治疗当前证据、熟悉监管评估流程并识别介入减重研究不足。
诊断标准与关键数值
- 未来介入减重治疗的理想治疗终点为6-12个月体重较基线下降>8%-10%。
临床应用与阅片要点
- 开展介入减重临床研究时应将6-12个月体重下降>8%-10%作为疗效终点。
- 设计介入减重试验时应优先采用盲法随机对照并设假手术对照,同时联合行为治疗。
局限性
- 原文为共识专家组会议纪要,未报告系统检索或证据分级方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The Society of Interventional Radiology Foundation commissioned a Research Consensus Panel to establish a research agenda on "Obesity Therapeutics" in interventional radiology (IR). The meeting convened a multidisciplinary group of physicians and scientists with expertise in obesity therapeutics. The meeting was intended to review current evidence on obesity therapies, familiarize attendees with the regulatory evaluation process, and identify research deficiencies in IR bariatric interventions, with the goal of prioritizing future high-quality research that would move the field forward. The panelists agreed that a weight loss of >8%-10% from baseline at 6-12 months is a desirable therapeutic endpoint for future IR weight loss therapies. The final consensus on the highest priority research was to design a blinded randomized controlled trial of IR weight loss interventions versus sham control arms, with patients receiving behavioral therapy.
引用
- Yuan F, Latif MA, Shafaat O, et al. Interventional Radiology Obesity Therapeutics: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol. 2021. PMID: 34462083. doi:10.1016/j.jvir.2021.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。